Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells

Endocrine-Related Cancer

Volumn 19, Issue 3, 2012, Pages 291-304

  Liu, Yu Yu ^a   Zhang, Xiaoli ^a   Ringel, Matthew D ^b   Jhiang, Sissy M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; SODIUM IODIDE I 125; SODIUM IODIDE SYMPORTER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TRANSPORT; DRUG UPTAKE; ENZYME INHIBITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; THYROID CELL;

ANIMALS; BENZYLAMINES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL LINE; CHROMONES; ENZYME INHIBITORS; FLAVONOIDS; HEK293 CELLS; HUMANS; IODINE RADIOISOTOPES; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; QUINOXALINES; RATS; RNA, MESSENGER; SIROLIMUS; SYMPORTERS; THYROID GLAND; THYROTROPIN;

EID: 84862682577     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0288     Document Type: Article

References (28)

1. - symporter distribution in human thyroid tissues: an immunohistochemical study. Journal of Clinical Endocrinology and Metabolism 83 4102-4106. (doi:10.1210/jc.83.11.4102)
2. Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC et al. 2008 Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. Journal of Clinical Investigation 118 3065-3074.
3. Cass LA & Meinkoth JL 2000 Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation. Oncogene 19 924-932. (doi:10.1038/sj.onc.1203393)
4. Castro MR, Bergert ER, Goellner JR, Hay ID & Morris JC 2001 Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. Journal of Clinical Endocrinology and Metabolism 86 5627-5632. (doi:10.1210/jc.86.11.5627)
5. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A &Avvedimento EV 2001 cAMP signaling selectively influences Ras effectors pathways. Oncogene 20 1186-1192. (doi:10.1038/sj.onc.1204219)
6. Garcia B & Santisteban P 2002 PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression. Molecular Endocrinology 16 342-352. (doi:10.1210/me.16.2.342)
7. Holm S 1979 A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6 65-70.
8. Hou P, Liu D, Ji M, Liu Z, Engles JM, Wahl RL & Xing M 2009 Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications. PLoS ONE 4 e6200. (doi:10.1371/journal.pone.0006200)
9. Iacovelli L, Capobianco L, Salvatore L, Sallese M, D'Ancona GM & De Blasi A 2001 Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Molecular Pharmacology 60 924-933. (Pubitemid 33027427)
10. Knauf JA & Fagin JA 2009 Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Current Opinion in Cell Biology 21 296-303. (doi:10.1016/j.ceb.2009.01.013)
11. Knauf JA, Kuroda H, Basu S & Fagin JA 2003 RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase. Oncogene 22 4406-4412. (doi:10.1038/sj.onc.1206602)
12. Kogai T, Ohashi E, Jacobs MS, Sajid-Crockett S, Fisher ML, Kanamoto Y & Brent GA 2008a Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways. Journal of Clinical Endocrinology and Metabolism 93 1884-1892. (doi:10.1210/jc.2007-1627)
13. Kogai T, Sajid-Crockett S, Newmarch LS, Liu YY & Brent GA 2008b Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells. Journal of Endocrinology 199 243-252. (doi:10.1677/JOE-08-0333)
14. Lee IH, Dinudom A, Sanchez-Perez A, Kumar S & Cook DI 2007 Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2. Journal of Biological Chemistry 282 29866-29873. (doi:10.1074/jbc. M701923200)
15. Lou L, Urbani J, Ribeiro-Neto F & Altschuler DL 2002 cAMP inhibition of Akt is mediated by activated and phosphorylated Rap1b. Journal of Biological Chemistry 277 32799-32806. (doi:10.1074/jbc.M201491200)
16. Marsee DK, Venkateswaran A, Tao H, Vadysirisack D, Zhang Z, Vandre DD & Jhiang SM 2004 Inhibition of heat shock protein 90, a novel RET/PTC1-associated protein, increases radioiodide accumulation in thyroid cells. Journal of Biological Chemistry 279 43990-43997. (doi:10.1074/jbc. M407503200)
17. Ohashi E, Kogai T, Kagechika H & Brent GA 2009 Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Research 69 3443-3450. (doi:10.1158/0008-5472.CAN-08-3234)
18. Patel A, Jhiang S, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM & Francis GL 2002 Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatric Research 52 737-744. (Pubitemid 35286044)
19. Riedel C, Levy O & Carrasco N 2001 Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. Journal of Biological Chemistry 276 21458-21463. (doi:10.1074/jbc.M100561200)
20. de Souza EC, Padron AS, Braga WM, de Andrade BM, Vaisman M, Nasciutti LE, Ferreira AC & de Carvalho DP 2010 MTOR downregulates iodide uptake in thyrocytes. Journal of Endocrinology 206 113-120. (doi:10.1677/JOE-09-0436)
21. Tsygankova OM, Kupperman E, Wen W & Meinkoth JL 2000 Cyclic AMP activates Ras. Oncogene 19 3609-3615. (doi:10.1038/sj.onc.1203680)
22. Tsygankova OM, Saavedra A, Rebhun JF, Quilliam LA &Meinkoth JL 2001 Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A. Molecular and Cellular Biology 21 1921-1929. (doi:10.1128/MCB.21.6.1921-1929.2001)
23. Vadysirisack DD, Chen ES, Zhang Z, Tsai MD, Chang GD &Jhiang SM 2007a Identification of in vivo phosphorylation sites and their functional significance in the sodium iodide symporter. Journal of Biological Chemistry 282 36820-36828. (doi:10.1074/jbc.M706817200)
24. Vadysirisack DD, Venkateswaran A, Zhang Z & Jhiang SM 2007b MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner. Endocrine-Related Cancer 14 421-432. (doi:10.1677/erc.1. 01263)
25. Wan X, Harkavy B, Shen N, Grohar P & Helman LJ 2007 Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26 1932-1940. (doi:10.1038/sj.onc.1209990)
26. Xing M 2010 Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid 20 697-706. (doi:10.1089/thy.2010.1646)
27. Yoshida T, Semprun-Prieto L, Sukhanov S & Delafontaine P 2010 IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. American Journal of Physiology. Heart and Circulatory Physiology 298 H1565-H1570. (doi:10.1152/ajpheart.00146.2010)
28. Zaballos MA, Garcia B & Santisteban P 2008 Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Molecular Endocrinology 22 1183-1199. (doi:10.1210/me.2007-0093)